Get the Stockscreener App
20.09
3.60%
-0.75
After Hours:
20.12
0.03
+0.15%
Sanara Medtech Inc stock is traded at $20.09, with a volume of 54,392.
It is down -3.60% in the last 24 hours and down -3.13% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
See More
Previous Close:
$20.84
Open:
$20.79
24h Volume:
54,392
Relative Volume:
1.03
Market Cap:
$179.52M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-38.63
EPS:
-0.52
Net Cash Flow:
$-3.51M
1W Performance:
+0.95%
1M Performance:
-3.13%
6M Performance:
-40.98%
1Y Performance:
-37.00%
1-Day Range:
$19.74
$20.93
1-Week Range:
$19.74
$21.18
52-Week Range:
$18.29
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
20.09 | 186.22M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
501.18 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.49 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.27 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.05 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.88 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - marketscreener.com
Sanara MedTech sets March 24 call to review 2025 results - Stock Titan
Sanara MedTech (SMTI) CEO has 491 shares withheld to cover tax on vesting - Stock Titan
Sanara MedTech Unveils 2026 Strategy in Investor Presentation - TipRanks
Sanara MedTech (NASDAQ: SMTI) furnishes 2026 outlook deck - Stock Titan
Weekly Recap: Can Sanara MedTech Inc maintain sales growthJuly 2025 Summary & Consistent Return Strategy Ideas - baoquankhu1.vn
SMTI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SMTI Should I Buy - Intellectia AI
SMTI PE Ratio & Valuation, Is SMTI Overvalued - Intellectia AI
Sanara MedTech (SMTI) COO has shares withheld to cover taxes - Stock Titan
Sanara MedTech (SMTI) CFO uses 437 shares to cover tax withholding - Stock Titan
Sanara MedTech (SMTI) Controller has 149 shares withheld for taxes - Stock Titan
(SMTI) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Reviewing Koninklijke Philips (NYSE:PHG) and Sanara MedTech (NASDAQ:SMTI) - Defense World
Patterns Watch: Whats next for Sanara MedTech Inc stockMarket Weekly Review & Weekly High Momentum Picks - baoquankhu1.vn
SMTI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sanara MedTech Inc. (SMTI) Stock Analysis: Unpacking a 103.56% Potential Upside for Investors - DirectorsTalk Interviews
Sanara MedTech (NASDAQ:SMTI) Shares Up 2.9%Time to Buy? - MarketBeat
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd - Bitget
Sanara MedTech Inc. to Present at TD Cowen 46th Annual Health Care Conference - Quiver Quantitative
Why Sanara MedTech Inc. stock is a must watch in 2025July 2025 Trends & Daily Stock Trend Reports - mfd.ru
(SMTI) Risk Channels and Responsive Allocation - Stock Traders Daily
What is Sanara MedTech Inc. s 5 year growth outlookShare Buyback & Weekly Stock Performance Updates - mfd.ru
Will Sanara MedTech Inc. stock see insider buyingIPO Watch & Stepwise Entry/Exit Trade Alerts - mfd.ru
Is Sanara MedTech Inc. undervalued by DCF analysisRate Cut & Real-Time Price Movement Reports - mfd.ru
Shareholders in Sanara MedTech (NASDAQ:SMTI) are in the red if they invested three years ago - Yahoo Finance
Can Sanara MedTech Inc. deliver consistent dividends2025 Market WrapUp & Reliable Entry Point Trade Alerts - mfd.ru
What margin trends mean for Sanara MedTech Inc. stockTrade Entry Report & Weekly Stock Performance Updates - mfd.ru
Will Sanara MedTech Inc. stock deliver shareholder valueWeekly Stock Recap & Long-Term Growth Stock Strategies - mfd.ru
Sanara Medtech's Growth Trajectory Gains Momentum Amid Strategic Shift () - aktiencheck.de
(SMTI) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Sanara MedTech’s Stock Under the Microscope: Niche Wound-Care Player Tests Investor Patience - AD HOC NEWS
Stop Loss: Is FNGS in a consolidation phasePortfolio Risk Report & Free Community Consensus Stock Picks - baoquankhu1.vn
HC Wainwright Predicts Weaker Earnings for Sanara MedTech - MarketBeat
Analysts Issue Forecasts for Sanara MedTech FY2025 Earnings - Defense World
Sanara MedTech FY2025 EPS Forecast Boosted by HC Wainwright - MarketBeat
SMTI Latest Analyst Rating Update: HC Wainwright & Co. Reiterates Buy | SMTI Stock News - GuruFocus
Sanara MedTech (NASDAQ:SMTI) Receives “Buy” Rating from HC Wainwright - Defense World
HC Wainwright Reiterates Buy Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Liquidity Mapping Around (SMTI) Price Events - Stock Traders Daily
Can Sanara MedTech Inc. stock outperform in a bear marketJuly 2025 Outlook & Capital Efficiency Focused Strategies - mfd.ru
Sanara MedTech expects 19% revenue growth for 2025, issues 2026 guidance - Investing.com Nigeria
Sanara MedTech reports Q4 preliminary net revenue $27.2M-$27.7M - TipRanks
SMTI Projects Revenue Growth for Q4 and Secures New Contract - GuruFocus
Sanara MedTech Reports Preliminary Financial Results for 2025 and Issues 2026 Guidance - Quiver Quantitative
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance - The Manila Times
Sanara MedTech Reports Unaudited Preliminary Financial Results For The Fourth Quarter And Full Year 2025 Introduces Full Year 2026 Financial Guidance - TradingView
Sanara MedTech Inc. Reports Unaudited Preliminary Financial - GlobeNewswire
Sanara MedTech Inc. (SMTI) Investor Outlook: Strong Buy Ratings Suggest 75% Upside Potential - DirectorsTalk Interviews
Sanara MedTech (NASDAQ:SMTI) Downgraded by Zacks Research to "Hold" - MarketBeat
Is Sanara MedTech Inc. stock a top performer YTDJuly 2025 Macro Moves & Growth Oriented Trade Recommendations - Bollywood Helpline
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):